Medcura

Based in the United States, Medcura is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Medcura develops hydrophobically modified biopolymer hemostatic products, including the LifeGel flowable hemostatic gel, to control minimal to moderate surgical bleeding. Their products are designed to provide mechanical mucoadhesive hemostasis with an emphasis on use in confined surgical spaces such as spine surgery.